NCT06445582View on ClinicalTrials.gov

SV2A-PET/CT and PET/MRI Combined Clinical Criteria Score in the Diagnosis of Early Cognitive Alteration

Not yet recruitingOBSERVATIONAL
Enrollment

80

Participants

Timeline

Start Date

June 30, 2024

Primary Completion Date

December 31, 2025

Study Completion Date

December 31, 2025

Conditions
Alzheimer Disease
Interventions
DIAGNOSTIC_TEST

[18F]SDM-8

synaptic vesicle glycoprotein 2 A（SV2A）PET tracer \[18F\]SDM-8

All Listed Sponsors
lead

Anhui Provincial Hospital

OTHER_GOV

NCT06445582 - SV2A-PET/CT and PET/MRI Combined Clinical Criteria Score in the Diagnosis of Early Cognitive Alteration | Biotech Hunter | Biotech Hunter